Related Experiment Video
Updated: Mar 1, 2026

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
Published on: June 2, 2022
Causal links between gut microbiota, plasma metabolites, and insomnia: Insights from Mendelian randomization
XuWen Zheng1, Jin Xu1, JinNan Yin1
1Department of Emergency, Wujin Hospital Affiliated with Jiangsu University and Wujin Clinical College of Xuzhou Medical University, Changzhou, Jiangsu, China.
Objectives:
This study explored the plasma metabolites' mediation effect between gut microbiomes and insomnia through Mendelian randomisation (MR).
Methods:
Using publicly accessible GWAS data from 5959 individuals for gut microbiota and 8299 individuals for plasma metabolites, we employed MR analysis to explore their causal effects on insomnia. Insomnia outcome data were obtained from Pan-UKB, GERA, and FinnGen, covering 9007 cases and 871,802 controls. Mediation effects of identified bacterial taxa on insomnia through plasma metabolites were computed using the product of coefficients approach.
Results:
Our MR analysis included participants with a mean age of 45.7 years (SD = 11.5) for gut microbiota and 63 years (range 45-85) for plasma metabolites. The analysis identified 10 gut microbiomes and 35 plasma metabolites potentially associated with insomnia respectively. Specifically, increased abundances of certain gut microbiomes, such as species CAG-145 sp000435615, were linked to a higher risk of insomnia. Mediation analysis revealed that the plasma metabolite 3-ethylcatechol sulphate levels significantly mediated the effects of these microbiomes on insomnia, explaining up to 31.49% of the total effect.
Conclusion:
This study highlights the role of gut microbiota in influencing insomnia risk, mediated through specific plasma metabolites. These findings provide valuable insights into the gut-brain axis and may inform the development of therapeutic targets for managing sleep disorders.
Insights
Gut bacteria influence insomnia risk through plasma metabolites. Specific gut microbiomes and 3-ethylcatechol sulphate levels mediate this connection, offering potential therapeutic targets for sleep disorders.
Area of Science:
- Microbiome research
- Metabolomics
- Sleep science
Background:
- The gut microbiome plays a role in the gut-brain axis.
- Understanding the link between gut microbiota and insomnia is crucial for public health.
- Plasma metabolites may mediate the effects of gut bacteria on sleep.
Purpose of the Study:
- To investigate the mediating role of plasma metabolites in the relationship between gut microbiomes and insomnia.
- To identify specific gut bacteria and plasma metabolites associated with insomnia.
- To explore potential therapeutic targets for insomnia based on gut-brain axis interactions.
Main Methods:
- Mendelian randomization (MR) analysis was used to explore causal relationships.
- Genome-wide association study (GWAS) data for gut microbiota and plasma metabolites were utilized.
- Mediation effects were calculated using the product of coefficients approach.
Main Results:
- Ten gut microbiomes and 35 plasma metabolites were found to be potentially associated with insomnia.
- Increased abundance of certain gut microbiomes, like CAG-145 sp000435615, correlated with higher insomnia risk.
- Plasma metabolite 3-ethylcatechol sulphate significantly mediated the effect of gut microbiomes on insomnia, explaining up to 31.49% of the total effect.
Conclusions:
- Gut microbiota composition influences insomnia risk.
- Plasma metabolites, such as 3-ethylcatechol sulphate, act as mediators in the gut-brain axis concerning insomnia.
- These findings suggest novel therapeutic strategies for managing insomnia by targeting the gut microbiome and its metabolites.
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Circadian Rhythms and Gene Regulation
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...

